[1] Polson J, Lee WM. American Association for the Study of Liver Disease. AASLD position paper: The management of Acute hepatic failure. Hepatology.2005;41(5):1179-1197.
[2] Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol.2004;40(2):192-197.
[3] 中华医学会感染病学分会肝衰竭与人工肝学组、中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14:643-646.
[4] Satin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure:consensus recommendations ofthe Asian Pacific Associationfor the study ofthe liver(APASL). Hepatol Int.2009; 3:269-282.
[5] Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the study of Liver Diseases Position Paper on acute fiver failure 2011. Hepatology.2012;55: 965-967.
[6] AASLD Position Paper: The Management of Acute Liver Failure:Up-date 2011[EB/OL] (2011-09)E2011-01-02]. http://www.aasld.org/practiceguidelines/Documents/AcuteLiverFailureUpdate2011.
[7] 中华医学会感染病学分会肝衰竭与人工肝学组、中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南(2012版) [J].中华肝脏病杂志,2013,21:177-183.
[8] Sass DA. Shakil AO. Fulminant hepatic failure.Liver Transpl. 2005;11:594-605.
[9] Bretheriek AD, Craig DG, Masterton G, et al. Acute liver failure in Scotland between 1992 and 2009:incidence,aetiology and outcome.OJM.2011;104:945-956.
[10] 王建锋,李霄,韩炜,等.急性肝衰竭的治疗进展[J].中华肝胆外科杂志,2012,18(12):957-960.
[11] Achilles A, Robert S, Ronald W, et al. Prospective, randomized, multicenter, controlled trial of a bioartifical liver in treat acute liver failure.Ann of Surg,2004;239(5):660-670.
[12] Olyaei AJ, deMattos AM, Bennett WM. Nephrotoxicity of immunosuppressive drugs : new insight and preventive strategies. Curr Opin Crit Care.2001;7(6):384-389.
[13] Shin HS, Kim SP, Han SH, et al. Prognostic indicators for acute liver failure development and mortality in patients with hepatitis a: consecutive case analysis. Yonsei Med J.2014; 55(4):953-959.
[14] Han YS, Lee SK, Joh JW, et al. outcomes of hepatitis B virus recurrence after liver transplantation. Transplant Proc. 2006; 38(7):2123-2124.
[15] Blei AT, Cordoba J. Practice Parameters Committee ofthe American College of Gastroenterology.Hepatic Encephalopathy. Am J Gastroenteml.2001;96:1968-1976.
[16] Pugh RN, MurrayLyon IM, Dawson JL, et al.Transection of the oesophagus for bleeding oesophageal varices.Br J Surg. 1973; 60:646-649.
[17] Kamath PS, Wiesner RH, Malinchoc M, et al A model tO predict survival in patients with end-stage liver disease.Hepatology.2001;33:464-470.
[18] Dhiman RK, Seth AK, Jain S, et al. Prognositic evaluation of early indicators in fulminant hepatic failure by multivariate analysis.Dig Dis Sci.1998;43:1311.
[19] 李兰娟.肝衰竭临床治疗中的难点和热点[J].中华肝脏病杂志,2012,20(6):405-407.
[20] Voigt MD. Predicting Death in Patients With Acetamin-ophen-Induced Acute Liver Failure:The King’s College Hospital Model Is on the SOFA,Not the Mat.Liver Transpl.2012;18:384-386.
[21] Kamath PS, Kim WR. The model for end-stage 1iver disease (MELD). Hepatology.2007;45:797-805.
[22] Mochida S.Indication criteria for liver transplantation for acute fiver failure in Japan.Hepatol Res.2008;38 Suppl l:S52-55.
[23] 饶慧瑛,郭芳,魏来.2005年美国肝病学会急性肝衰竭诊治和肝移植患者评价指南简介[J].中华肝脏病杂志,2006,14(2):154-156.
[24] Jain S, Pendyala P, Varma S, et al.Effect of renal dysfunction in fulminant hepatic failure. Trop Gastro.2000;21(3):118-120.
[25] Patrono D, Brunati A, Romagnoli R, et al. Liver transplantation after severe hepatic trauma: a sustainable practice. A single-center experience and review of the literature.Clin Transplant.2013;27(4):E528-37.
[26] Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med.1993;21(3):328-338.
[27] Ostapowicz GA, Fontana RJ, Schi odt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med.2002;137(12): 947-954.
[28] Karidis NP, Kouraklis G, Theocharis SE. Platelet activating factor in liver injury: a relational scope. World J Gastroenter ol. 2006;12(23):3695-3706.
[29] Jung O, Asbe Vollkopf A, Betz C, et al. Long term therapy of acute liver failure to successful transplantation with an extra corporealliver support system. Gastroenterol.2007; 45(1):21.
[30] Steadman RH, Van Rensburg A, KrRnler DJ. Transplantation for acute liver failure:perioperative management.Curt Opin Organ Transplant.2010;15:368-373.
[31] Mochida S.Indication criteria for liver transplantation for acute fiver failure in Japan.Hepatol Res.2008;38 Suppl l:S52-55.
[32] Ling Q, Xu X, Wei Q, et al. Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure.PLoS One.2012;7: e30322.
[33] Fontana RJ, Ellerbe C, Durkalski VE, et al.Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int. 2014 Jul 12.[Epub ahead of print]
[34] Manka P, Olliges V, Bechmann LP,et al.Low levels of blood lipids are associated with etiology and lethal outcome in acute liver failure.PLoS One. 2014;9(7):e102351.
[35] Sampaio MS, Martin P, Bunnapradist S.Renal Dysfunction in End-Stage Liver Disease and Post-Liver Transplant.Clin Liver Dis. 2014;18(3):543-560.
[36] Shin HS, Kim SP, Han SH,et al.Prognostic indicators for acute liver failure development and mortality in patients with hepatitis a: consecutive case analysis.Yonsei Med J. 2014; 55(4): 953-959.
[37] Kaido T, Tomiyama K, Ogawa K,et al.Section 12. Living donor liver transplantation for patients with high model for end-stage liver disease scores and acute liver failure.Transplantation. 2014; 97 Suppl 8:S46-7.
[38] Wu FL, Shi KQ, Chen YP,et al.Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review.Expert Rev Gastroenterol Hepatol. 2014;8(6):623-632.
[39] Koch A, Zimmermann HW, Gassler N, et al.Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure. Liver Int. 2014 Feb 28. [Epub ahead of print].
[40] Zheng YB, Huang ZL, Wu ZB,et al.Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study.Int J Med Sci. 2013;10(12):1658-1664. |